CAREDX, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
CAREDX, INC. (CDNA) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $2.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-07-30
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.24M, a 7.06% decline year-over-year.
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $1.42M, a 5.90% increase year-over-year.
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $1.38M, a 3.84% increase year-over-year.
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.35M, a 5.00% decline year-over-year.
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $5.40M, a 2.97% decline from fiscal 2024.
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $5.56M, a 2.30% increase from fiscal 2023.
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $5.44M, a 23.25% increase from fiscal 2022.
- CAREDX, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $4.41M, a 42.88% increase from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.66M 10-Q · filed 2026-07-30 | $4.03M derived: sum of 3 quarters · filed 2026-07-30 | $5.38M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $1.42M 10-Q · filed 2026-04-28 | $2.80M derived: sum of 2 quarters · filed 2026-04-28 | $4.15M derived: sum of 3 quarters · filed 2026-04-28 | $5.48M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.73M derived: sum of 2 quarters · filed 2026-02-25 | $4.06M derived: sum of 3 quarters · filed 2026-07-30 | $5.40M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.68M derived: sum of 2 quarters · filed 2026-07-30 | $4.02M 10-Q · filed 2025-11-04 | $5.35M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.67M 10-Q · filed 2026-07-30 | $4.00M derived: sum of 3 quarters · filed 2026-07-30 | $5.42M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $1.34M 10-Q · filed 2026-04-28 | $2.67M derived: sum of 2 quarters · filed 2026-04-28 | $4.09M derived: sum of 3 quarters · filed 2026-04-28 | $5.50M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.75M derived: sum of 2 quarters · filed 2026-02-25 | $4.16M derived: sum of 3 quarters · filed 2026-02-25 | $5.56M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.83M derived: sum of 2 quarters · filed 2025-11-04 | $4.24M 10-Q · filed 2025-11-04 | $5.65M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.82M 10-Q · filed 2025-08-06 | $4.23M derived: sum of 3 quarters · filed 2026-02-25 | $5.60M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.40M 10-Q · filed 2025-04-30 | $2.82M derived: sum of 2 quarters · filed 2026-02-25 | $4.19M derived: sum of 3 quarters · filed 2026-02-25 | $5.50M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.79M derived: sum of 2 quarters · filed 2026-02-25 | $4.10M derived: sum of 3 quarters · filed 2026-02-25 | $5.44M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $2.68M derived: sum of 2 quarters · filed 2024-11-04 | $4.02M 10-Q · filed 2024-11-04 | $5.31M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $2.65M 10-Q · filed 2024-07-31 | $3.94M derived: sum of 3 quarters · filed 2025-02-28 | $5.24M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $1.34M 10-Q · filed 2024-05-09 | $2.63M derived: sum of 2 quarters · filed 2025-02-28 | $3.93M derived: sum of 3 quarters · filed 2025-02-28 | $4.83M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $2.59M derived: sum of 2 quarters · filed 2025-02-28 | $3.50M derived: sum of 3 quarters · filed 2025-02-28 | $4.41M 10-K · filed 2025-02-28 |
| 2022-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $2.21M derived: sum of 2 quarters · filed 2023-11-08 | $3.12M 10-Q · filed 2023-11-08 | $4.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $907.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.82M 10-Q · filed 2023-08-08 | $2.72M derived: sum of 3 quarters · filed 2024-02-28 | $3.54M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $915.00K 10-Q · filed 2023-05-10 | $1.82M derived: sum of 2 quarters · filed 2024-02-28 | $2.64M derived: sum of 3 quarters · filed 2024-02-28 | $3.33M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $901.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.72M derived: sum of 2 quarters · filed 2024-02-28 | $2.41M derived: sum of 3 quarters · filed 2024-02-28 | $3.09M 10-K · filed 2024-02-28 |
| 2021-09-30 | $821.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.51M derived: sum of 2 quarters · filed 2022-11-03 | $2.19M 10-Q · filed 2022-11-03 | $2.83M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $689.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.37M 10-Q · filed 2022-08-04 | $2.01M derived: sum of 3 quarters · filed 2023-02-27 | |
| 2021-03-31 | $677.00K 10-Q · filed 2022-05-05 | $1.32M derived: sum of 2 quarters · filed 2023-02-27 | ||
| 2020-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $2.54M 10-K · filed 2023-02-27 | ||
| 2020-09-30 | $1.90M 10-Q · filed 2021-10-28 | |||
| 2019-12-31 | $1.62M 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |